Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Description

The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.

Conditions

Smoking Cessation

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT): Pilot Intervention and Assessment of Barriers and Facilitators of Implementation

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Condition
Smoking Cessation
Intervention / Treatment

-

Contacts and Locations

Anchorage

Anchorage Native Primary Care Center, Anchorage, Alaska, United States, 99508

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Alaska Native or American Indian person by self-report
  • * eligible for or already receiving services at Southcentral Foundation (SCF)
  • * age 18 years or older
  • * daily smoking in the past 30-days
  • * if other nicotine or tobacco products are used, cigarettes are main product used
  • * planning to schedule an appointment with the Quit Tobacco Program to seek smoking cessation treatment in the next 30 days
  • * willing to make a quit attempt within 30 days of enrollment in the Quit Tobacco Program
  • * willing to have a blood test to inform their treatment
  • * willing to try a pharmacologic treatment
  • * willing to provide a saliva sample
  • * has phone service
  • * has access to broadband internet on mobile phone at home, work, or other location
  • * has an Android or iPhone mobile phone compatible with the Smokerlyzer app
  • * Participated in the prior study phase
  • * participated in a cessation program during the past 3 months
  • * their provider has not approved varenicline in their referral to the Quit Tobacco Program
  • * has history of serious hypersensitivity or skin reactions to varenicline
  • * has bleeding disorder or is currently receiving cancer treatment
  • * questionable capacity or impaired decision-making capacity

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Southcentral Foundation,

Georgia J Michlig, PhD, PRINCIPAL_INVESTIGATOR, Southcentral Foundation

Study Record Dates

2025-05